Jingjing Wu
Chaigoubu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
USP5 inhibition stimulates immunogenic ferroptosis that enhances immunotherapy in diffuse large B-cell lymphoma.
Journal: Cell communication and signaling : CCS
Published: July 08, 2025
Spautin-1 inhibits the growth of diffuse large B-cell lymphoma by inducing mitochondrial damage-mediated PANoptosis and anti-tumor immunity.
Journal: Cancer immunology, immunotherapy : CII
Published: February 11, 2025
Erratum: Author correction to "DNA damage repair promotion in colonic epithelial cells by andrographolide downregulated cGAS‒STING pathway activation and contributed to the relief of CPT-11-induced intestinal mucositis" [Acta Pharmaceutica Sinica B 12 (2022) 262-273].
Journal: Acta pharmaceutica Sinica. B
Published: July 31, 2023
Deubiquitinase inhibitor PR-619 potentiates colon cancer immunotherapy by inducing ferroptosis.
Journal: Immunology
Published: June 04, 2023
Suchilactone inhibits the growth of acute myeloid leukaemia by inactivating SHP2.
Journal: Pharmaceutical biology
Published: December 28, 2021
Targeting tumor endothelial hyperglycolysis enhances immunotherapy through remodeling tumor microenvironment.
Journal: Acta pharmaceutica Sinica. B
Published: November 09, 2021
DNA damage repair promotion in colonic epithelial cells by andrographolide downregulated cGAS‒STING pathway activation and contributed to the relief of CPT-11-induced intestinal mucositis.
Journal: Acta pharmaceutica Sinica. B
Published: January 09, 2021
SHP2-Mediated Inhibition of DNA Repair Contributes to cGAS-STING Activation and Chemotherapeutic Sensitivity in Colon Cancer.
Journal: Cancer research
Published: November 12, 2020
ASPM Predicts Poor Clinical Outcome and Promotes Tumorigenesis for Diffuse Large B-cell Lymphoma.
Journal: Current cancer drug targets
Published: May 27, 2020
ZFX promotes tumorigenesis and confers chemotherapy resistance in esophageal squamous cell carcinoma.
Journal: Clinics and research in hepatology and gastroenterology
Published: May 08, 2020
Apatinib suppresses tumor progression and enhances cisplatin sensitivity in esophageal cancer via the Akt/β-catenin pathway.
Journal: Cancer cell international
Published: January 27, 2020
USP9X mRNA expression predicts clinical outcome for esophageal squamous cell carcinoma treated with cisplatin-based therapy.
Journal: Clinics and research in hepatology and gastroenterology
Published: August 07, 2019
Last Updated: 09/26/2026